Alpha 2.0
Login Register
» Authors » G Tsirakis

G Tsirakis

Explore the profile of G Tsirakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 155
Followers 0
Related Specialties
Oncology
Biochemistry
Hematology
Top 10 Co-Authors
M G Alexandrakis
C A Pappa
A Boula
E N Stathopoulos
A Alegakis
D S Kyriakou
F E Psarakis
K Sfiridaki
F H Passam
A Xekalou
Published In
Med Oncol
Cytokine
Leuk Res
Int J Biol Markers
Eur J Intern Med
Affiliations
Soon will be listed here.
Recent Articles
11.
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment
Sfiridaki K, Pappa C, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, et al.
Mediators Inflamm . 2011 Sep; 2011:867576. PMID: 21941412
An essential cytokine system for the osteoclast biology in multiple myeloma (MM) consists of the receptor of activator of NF-κB ligand (RANKL), its receptor (RANK), and the soluble decoy receptor,...
12.
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma
Pappa C, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, et al.
Cytokine . 2011 Sep; 56(3):616-20. PMID: 21940178
Background: The ELR+ CXC chemokines are important mediators of tumorigenesis, related to their angiogenic properties. Angiogenesis appears to be a prominent feature in the progression of multiple myeloma (MM). CXC...
13.
Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma
Pappa C, Miyakis S, Tsirakis G, Sfiridaki A, Alegakis A, Kafousi M, et al.
Cytokine . 2007 Apr; 37(2):171-5. PMID: 17446083
In order to determine prognostic factors characterizing multiple myeloma (MM) cell kinetics, bone marrow proliferative activity and serum Interleukin-10 (IL-10), and Interleukin-15 (IL-15) levels were measured in 40 newly diagnosed...
14.
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density
Alexandrakis M, Passam F, Pappa C, Damilakis J, Tsirakis G, Kandidaki E, et al.
Int J Immunopathol Pharmacol . 2005 May; 18(2):287-95. PMID: 15888251
Recent studies have documented that angiogenesis plays a significant role in haematological malignancies, including mylodysplastic syndromes (MDS). Basic fibroblast growth factor (b-FGF), Hepatocyte growth factor (HGF) and Tumor necrosis factor-alpha...
15.
Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance
Passam F, Tsirakis G, Boula A, Fragou A, Consolas I, Alegakis A, et al.
Clin Lab Haematol . 2004 Dec; 26(6):391-5. PMID: 15595996
The aim of this study was to assess circulating soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and interleukin-1beta (IL-1beta) in myelodysplastic syndromes (MDS) in order to...
16.
Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines
Alexandrakis M, Passam F, Sfiridaki A, Pappa C, Moschandrea J, Kandidakis E, et al.
Int J Biol Markers . 2004 Apr; 19(1):52-7. PMID: 15077927
Background: Leptin, apart from the regulation of food intake, has been implicated in hematopoiesis, the immune response and angiogenesis. Leptin has been found to be decreased in various hematological malignancies....